Attenuation of experimental asthma by mycobacterial protein combined with CpG requires a TLR9-dependent IFN-γ-CCR2 signalling circuit

Clinical and Experimental Allergy

Volumn 45, Issue 9, 2015, Pages 1459-1471

  Prado, R Q ^a   Bertolini, T B ^a   Pineros A R ^a   Gembre, A F ^a   Ramos, S G ^a   Silva, C L ^a   Borges, M C ^a   Bonato, V L D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CpG; Experimental asthma; Mycobacterial protein; TLR9

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 65; OVALBUMIN; TOLL LIKE RECEPTOR 9; BACTERIAL PROTEIN; CCR2 PROTEIN, MOUSE; CHAPERONIN 60; CPG-OLIGONUCLEOTIDE; HEAT-SHOCK PROTEIN 65, MYCOBACTERIUM; OLIGODEOXYRIBONUCLEOTIDE; TLR9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EOSINOPHILIA; EXPERIMENTAL ASTHMA; FEMALE; IMMUNOMODULATION; IMMUNOTHERAPY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT ALLERGY; SENSITIZATION; TH1 CELL; TH2 CELL; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; DRUG EFFECTS; GENETICS; HELPER CELL; IMMUNOLOGY; KNOCKOUT MOUSE; MYCOBACTERIUM LEPRAE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ASTHMA; BACTERIAL PROTEINS; CHAPERONIN 60; IMMUNOTHERAPY; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYCOBACTERIUM LEPRAE; OLIGODEOXYRIBONUCLEOTIDES; RECEPTORS, CCR2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TOLL-LIKE RECEPTOR 9;

EID: 84939625111     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12564     Document Type: Article

References (34)

1. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18:716-25.
2. Akdis CA. Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med 2012; 18:736-49.
3. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007; 13:552-9.
4. Hennessy EJ, Parker AE, O'Neill LA. Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 2010; 9:293-307.
5. Rha Y, Taube C, Haczku A et al. Effect of microbial heat shock proteins on airway inflammation and hyperresponsiveness. J Immunol 2002; 169:5300-7.
6. Patel M, Xu D, Kewin P et al. TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol 2005; 174:7558-63.
7. Hollingsworth JW, Whitehead GS, Lin KL et al. TLR4 signaling attenuates ongoing allergic inflammation. J Immunol 2006; 176:5856-62.
8. Xirakia C, Koltsida O, Stavropoulos A et al. Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am J Respir Crit Care Med 2010; 181:1207-16.
9. Wu ZQ, Xu YP, Xiang H, Shen HH. Effects of CpG oligodeoxynucleotide on transcription factors GATA-3 and T-bet mRNA expression in asthmatic mice. Acta Pharmacol Sin 2005; 26:1117-22.
10. Jain VV, Businga TR, Kitagaki K, George CL, O'Shaughnessy PT, Kline JN. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am J Physiol Lung Cell Mol Physiol 2003; 285:L1137-46.
11. Kitagaki K, Jain VV, Businga TR, Hussain I, Kline JN. Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses. Clin Diagn Lab Immunol 2002; 9:1260-9.
12. Kitagaki K, Businga TR, Kline JN. Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice. Clin Exp Immunol 2006; 143:249-59.
13. Shi C, Jia T, Mendez-Ferrer S et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 2011; 34:590-601.
14. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011; 11:762-74.
15. Fonseca DM, Paula MO, Wowk PF et al. IFN-γ-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN. Immunol Cell Biol 2011; 89:777-85.
16. Fonseca DM, Wowk PF, Paula MO et al. Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway. Clin Exp Allergy 2012; 42:131-43.
17. Souza PR, Zárate-Bladés CR, Hori JI et al. Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis. Expert Opin Biol Ther 2008; 8:1255-64.
18. Portaro FC, Hayashi MA, De Arauz LJ et al. The Mycobacterium leprae hsp65 displays proteolytic activity. Mutagenesis studies indicate that the M. leprae hsp65 proteolytic activity is catalytically related to the HslVU protease. Biochemistry 2002; 41:7400-6.
19. Shin YS, Takeda K, Shiraishi Y et al. Microbial heat shock protein 65 attenuates airway hyperresponsiveness and inflammation by modulating the function of dendritic cells. J Immunol 2012; 189:3404-10.
20. Serebrisky D, Teper AA, Huang CK et al. CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma. J Immunol 2000; 165:5906-12.
21. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-84.
22. Vabulas RM, Ahmad-Nejad P, da Costa C et al. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001; 276:31332-9.
23. Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006; 7:311-7.
24. Pietras EM, Miller LS, Johnson CT, O'Connell RM, Dempsey PW, Cheng G. A MyD88-dependent IFNγR-CCR2 signaling circuit is required for mobilization of monocytes and host defense against systemic bacterial challenge. Cell Res 2011; 21:1068-79.
25. Gonçalves ED, Bonato VL, da Fonseca DM et al. Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming. Genet Vaccines Ther 2007; 5:7.
26. Santos RR, Sartori A, Lima DS et al. DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes. J Immune Based Ther Vaccines 2009; 7:4.
27. Fedatto PF, Sérgio CA, Paula MO et al. Protection conferred by heterologous vaccination against tuberculosis is dependent on the ratio of CD4(+)/CD4(+) Foxp3(+) cells. Immunology 2012; 137:239-48.
28. Ramaprakash H, Hogaboam CM. Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and -independent manner. Int Arch Allergy Immunol 2010; 152:98-112.
29. Zhou Q, Ho AW, Schlitzer A et al. GM-CSF-licensed CD11b+ lung dendritic cells orchestrate Th2 immunity to blomia tropicalis. J Immunol 2014; 193:496-509.
30. Egawa M, Mukai K, Yoshikawa S et al. Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity 2013; 38:570-80.
31. Robays LJ, Maes T, Lebecque S et al. Chemokine receptor CCR2 but not CCR5 or CCR6 mediates the increase in pulmonary dendritic cells during allergic airway inflammation. J Immunol 2007; 178:5305-11.
32. Bokhari SM, Kim KJ, Pinson DM, Slusser J, Yeh HW, Parmely MJ. NK cells and gamma interferon coordinate the formation and function of hepatic granulomas in mice infected with the Francisella tularensis live vaccine strain. Infect Immun 2008; 76:1379-89.
33. Goldszmid RS, Caspar P, Rivollier A et al. NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 2012; 36:1047-59.
34. Iijima N, Mattei LM, Iwasaki A. Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue. Proc Natl Acad Sci U S A 2011; 108:284-9.